|
1
|
Albers GW, Caplan LR, Easton JD, Fayad PB,
Mohr JP, Saver JL and Sherman DG; TIA Working Group: Transient
ischemic attack-proposal for a new definition. N Engl J Med.
347:1713–1716. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Albers GW: Acute cerebrovascular syndrome:
Time for new terminology for acute brain ischemia. Nat Clin Pract
Cardiovasc Med. 3:5212006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mendis S, Davis S and Norrving B:
Organizational update: The world health organization global status
report on noncommunicable diseases 2014; one more landmark step in
the combat against stroke and vascular disease. Stroke.
46:e121–e122. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sarikaya H, Ferro J and Arnold M: Stroke
prevention-medical and lifestyle measures. Eur Neurol. 73:150–157.
2015. View Article : Google Scholar
|
|
5
|
Jickling GC and Sharp FR: Biomarker panels
in ischemic stroke. Stroke. 46:915–920. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang Z, Lin Y, Liu Y, Chen Y, Wang B, Li
C, Yan S, Wang Y and Zhao W: Serum uric acid levels and outcomes
after acute ischemic stroke. Mol Neurobiol. 2015.Epub ahead of
print.
|
|
7
|
Rodrigo J, Fernández AP, Serrano J,
Peinado MA and Martínez A: The role of free radicals in cerebral
hypoxia and ischemia. Free Radic Biol Med. 39:26–50. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Terpolilli NA, Moskowitz MA and Plesnila
N: Nitric oxide: Considerations for the treatment of ischemic
stroke. J Cereb Blood Flow Metab. 32:1332–1346. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Garry PS, Ezra M, Rowland MJ, Westbrook J
and Pattinson KT: The role of the nitric oxide pathway in brain
injury and its treatment-from bench to bedside. Exp Neurol.
263:235–243. 2015. View Article : Google Scholar
|
|
10
|
Ho JJ, Man HS and Marsden PA: Nitric oxide
signaling in hypoxia. J Mol Med (Berl). 90:217–231. 2012.
View Article : Google Scholar
|
|
11
|
Ito Y, Ohkubo T, Asano Y, Hattori K,
Shimazu T, Yamazato M, Nagoya H, Kato Y and Araki N: Nitric oxide
production during cerebral ischemia and reperfusion in eNOS- and
nNOS-knockout mice. Curr Neurovasc Res. 7:23–31. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Martínez-Murillo R, Fernández AP, Serrano
J, Rodrigo J, Salas E, Mourelle M and Martínez A: The nitric oxide
donor LA 419 decreases brain damage in a focal ischemia model.
Neurosci Lett. 415:149–153. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Willmot M, Gray L, Gibson C, Murphy S and
Bath PM: A systematic review of nitric oxide donors and L-arginine
in experimental stroke; effects on infarct size and cerebral blood
flow. Nitric Oxide. 12:141–149. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Paspalj D, Nikic P, Savic M, Djuric D,
Simanic I, Zivkovic V, Jeremic N, Srejovic I and Jakovljevic V:
Redox status in acute ischemic stroke: Correlation with clinical
outcome. Mol Cell Biochem. 406:75–81. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Serrano J, Uttenthal LO, Martínez A,
Fernández AP, Martínez de Velasco J, Alonso D, Bentura ML,
Santacana M, Gallardo JR, Martínez-Murillo R, et al: Distribution
of adrenomedullin-like immunoreactivity in the rat central nervous
system by light and electron microscopy. Brain Res. 853:245–268.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
López J and Martínez A: Cell and molecular
biology of the multifunctional peptide, adrenomedullin. Int Rev
Cytol. 221:1–92. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Garayoa M, Martínez A, Lee S, Pío R, An
WG, Neckers L, Trepel J, Montuenga LM, Ryan H, Johnson R, et al:
Hypoxia-inducible factor-1 (HIF-1) up-regulates adrenomedullin
expression in human tumor cell lines during oxygen deprivation: A
possible promotion mechanism of carcinogenesis. Mol Endocrinol.
14:848–862. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Serrano J, Alonso D, Encinas JM, Lopez JC,
Fernandez AP, Castro-Blanco S, Fernández-Vizarra P, Richart A,
Bentura ML, Santacana M, et al: Adrenomedullin expression is
up-regulated by ischemia-reperfusion in the cerebral cortex of the
adult rat. Neuroscience. 109:717–731. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Serrano J, Fernández AP, Sánchez J,
Rodrigo J and Martínez A: Adrenomedullin expression is up-regulated
by acute hypobaric hypoxia in the cerebral cortex of the adult rat.
Brain Pathol. 18:434–442. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Somay G, Halac GU, Uslu E and Aydin S:
Plasma adrenomedullin in acute ischemic stroke. Neurosciences
(Riyadh). 12:351–353. 2007.
|
|
21
|
Hurtado O, Serrano J, Sobrado M, Fernández
AP, Lizasoain I, Martínez-Murillo R, Moro MA and Martínez A: Lack
of adrenomedullin, but not complement factor H, results in larger
infarct size and more extensive brain damage in a focal ischemia
model. Neuroscience. 171:885–892. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Duangjit S, Muangpaisan W,
Chotinaiwattarakul W and Dharmasaroja P: Functional recovery at 3
months in stroke patients not receiving thrombolytic therapy: The
comparison between patients arriving earlier and later than 4.5 h.
J Stroke Cerebrovasc Dis. 23:91–98. 2014. View Article : Google Scholar
|
|
23
|
Berzina G, Sveen U, Paanalahti M and
Sunnerhagen KS: Analysing the modified rankin scale using concepts
of the international classification of functioning, disability and
health. Eur J Phys Rehabil Med. 2015.Epub ahead of print.
PubMed/NCBI
|
|
24
|
Blanco JR, Jarrin I, Martinez A, Siles E,
Larrayoz IM, Cañuelo A, Gutierrez F, Gonzalez-Garcia J, Vidal F and
Moreno S: CoRIS-Biobanco: Shorter telomere length predicts poorer
immunological recovery in virologically suppressed HIV-1-infected
patients treated with combined antiretroviral therapy. J Acquir
Immune Defic Syndr. 68:21–29. 2015. View Article : Google Scholar
|
|
25
|
Martínez A, Elsasser TH, Bhathena SJ, Pío
R, Buchanan TA, Macri CJ and Cuttitta F: Is adrenomedullin a causal
agent in some cases of type 2 diabetes? Peptides. 20:1471–1478.
1999. View Article : Google Scholar
|
|
26
|
Geeganage C, Tracy M, England T, Sare G,
Moulin T, Woimant F, Christensen H, De Deyn PP, Leys D, O'Neill D,
et al: Relationship between baseline blood pressure parameters
(including mean pressure, pulse pressure and variability), and
early outcome after stroke: Data from the tinzaparin in acute
ischaemic stroke trial (TAIST). Stroke. 42:491–493. 2011.
View Article : Google Scholar
|
|
27
|
Minnerup J, Wersching H, Unrath M and
Berger K: Explaining the decrease of in-hospital mortality from
ischemic stroke. PLoS One. 10:e01314732015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pikija S, Trkulja V, Malojcic B,
Mutzenbach JS and Sellner J: A high burden of ischemic stroke in
regions of Eastern/Central Europe is largely due to modifiable risk
factors. Curr Neurovasc Res. 12:341–352. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Morales Vidal SG and Ruland S: Platelet
antiaggregants in stroke prevention. Neurol Clin. 31:633–657. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hiramoto JS, Katz R, Weisman S and Conte
M: Gender-specific risk factors for peripheral artery disease in a
voluntary screening population. J Am Heart Assoc. 3:e0006512014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Stroke Unit Trialists' Collaboration:
Organised inpatient (stroke unit) care for stroke. Cochrane
Database Syst Rev. 9:CD0001972013.PubMed/NCBI
|
|
32
|
Ishitsuka K, Kamouchi M, Hata J, Fukuda K,
Matsuo R, Kuroda J, Ago T, Kuwashiro T, Sugimori H, Nakane H, et
al: High blood pressure after acute ischemic stroke is associated
with poor clinical outcomes: Fukuoka stroke registry. Hypertension.
63:54–60. 2014. View Article : Google Scholar
|
|
33
|
Tziomalos K, Giampatzis V, Bouziana SD,
Spanou M, Papadopoulou M, Kostaki S, Dourliou V, Papagianni M,
Savopoulos C and Hatzitolios AI: Elevated diastolic but not
systolic blood pressure increases mortality risk in hypertensive
but not normotensive patients with acute ischemic stroke. Am J
Hypertens. 28:765–771. 2015. View Article : Google Scholar
|
|
34
|
Yong M, Diener HC, Kaste M and Mau J:
Characteristics of blood pressure profiles as predictors of
long-term outcome after acute ischemic stroke. Stroke.
36:2619–2625. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wohlfahrt P, Krajcoviechova A, Jozifova M,
Mayer O, Vanek J, Filipovsky J and Cifkova R: Low blood pressure
during the acute period of ischemic stroke is associated with
decreased survival. J Hypertens. 33:339–345. 2015. View Article : Google Scholar
|
|
36
|
Vemmos KN, Tsivgoulis G, Spengos K,
Zakopoulos N, Synetos A, Manios E, Konstantopoulou P and Mavrikakis
M: U-shaped relationship between mortality and admission blood
pressure in patients with acute stroke. J Intern Med. 255:257–265.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bath PM, Martin RH, Palesch Y, Cotton D,
Yusuf S, Sacco R, Diener HC, Toni D, Estol C and Roberts R; PRoFESS
Study Group: Effect of telmisartan on functional outcome,
recurrence and blood pressure in patients with acute mild ischemic
stroke: A PRoFESS subgroup analysis. Stroke. 40:3541–3546. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Potter J, Mistri A, Brodie F, Chernova J,
Wilson E, Jagger C, James M, Ford G and Robinson T: Controlling
hypertension and hypotension immediately post stroke (CHHIPS)-a
randomised controlled trial. Health Technol Assess. 13:iiiix–xi.
2009. View Article : Google Scholar
|
|
39
|
Sandset EC, Bath PM, Boysen G, Jatuzis D,
Kõrv J, Lüders S, Murray GD, Richter PS, Roine RO, Terént A, et al:
The angiotensin-receptor blocker candesartan for treatment of acute
stroke (SCAST): A randomised, placebo-controlled, double-blind
trial. Lancet. 377:741–750. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sandset EC, Murray GD, Bath PM, Kjeldsen
SE and Berge E; Scandinavian Candesartan Acute Stroke Trial (SCAST)
Study Group: Relation between change in blood pressure in acute
stroke and risk of early adverse events and poor outcome. Stroke.
43:2108–2114. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Bath PM and Krishnan K: Interventions for
deliberately altering blood pressure in acute stroke. Cochrane
Database Syst Rev. 10:CD0000392014.PubMed/NCBI
|
|
42
|
Stead LG, Gilmore RM, Vedula KC, Weaver
AL, Decker WW and Brown RD Jr: Impact of acute blood pressure
variability on ischemic stroke outcome. Neurology. 66:1878–1881.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Fukuda K, Kai H, Kamouchi M, Hata J, Ago
T, Nakane H, Imaizumi T and Kitazono T; FSR Investigators; steering
committee of the Fukuoka Stroke Registry included: Day-by-day blood
pressure variability and functional outcome after acute ischemic
stroke: Fukuoka stroke registry. Stroke. 46:1832–1839. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Rashid PA, Whitehurst A, Lawson N and Bath
PM: Plasma nitric oxide (nitrate/nitrite) levels in acute stroke
and their relationship with severity and outcome. J Stroke
Cerebrovasc Dis. 12:82–87. 2003. View Article : Google Scholar
|
|
45
|
Abdullah A, Ssefer V, Ertugrul U, Osman E,
Esref A, Ugur CM, Adalet A, Yavuz Y, Faysal E and Nebahat T:
Evaluation of serum oxidant/antioxidant balance in patients with
acute stroke. J Pak Med Assoc. 63:590–593. 2013.PubMed/NCBI
|
|
46
|
Cure MC, Tufekci A, Cure E, Kirbas S,
Ogullar S, Kirbas A, Unal H, Yuce S and Cakmak S: Low-density
lipoprotein subfraction, carotid artery intima-media thickness,
nitric oxide and tumor necrosis factor alpha are associated with
newly diagnosed ischemic stroke. Ann Indian Acad Neurol.
16:498–503. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Gonullu H, Aslan M, Karadas S, Kati C,
Duran L, Milanlioglu A, Aydin MN and Demir H: Serum prolidase
enzyme activity and oxidative stress levels in patients with acute
hemorrhagic stroke. Scand J Clin Lab Invest. 74:199–205. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Molnar T, Pusch G, Papp V, Feher G,
Szapary L, Biri B, Nagy L, Keki S and Illes Z: The L-arginine
pathway in acute ischemic stroke and severe carotid stenosis:
Temporal profiles and association with biomarkers and outcome. J
Stroke Cerebrovasc Dis. 23:2206–2214. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Salom MG, Arregui B, Carbonell LF, Ruiz F,
González-Mora JL and Fenoy FJ: Renal ischemia induces an increase
in nitric oxide levels from tissue stores. Am J Physiol Regul
Integr Comp Physiol. 289:R1459–R1466. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Cui X, Chopp M, Zacharek A, Zhang C,
Roberts C and Chen J: Role of endothelial nitric oxide synthetase
in arteriogenesis after stroke in mice. Neuroscience. 159:744–750.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Khan M, Sekhon B, Giri S, Jatana M, Gilg
AG, Ayasolla K, Elango C, Singh AK and Singh I:
S-Nitrosoglutathione reduces inflammation and protects brain
against focal cerebral ischemia in a rat model of experimental
stroke. J Cereb Blood Flow Metab. 25:177–192. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zhang H, Tang B, Yin CG, Chen Y, Meng QL,
Jiang L, Wang WP and Niu GZ: Plasma adrenomedullin levels are
associated with long-term outcomes of acute ischemic stroke.
Peptides. 52:44–48. 2014. View Article : Google Scholar
|
|
53
|
Xia CF, Yin H, Borlongan CV, Chao J and
Chao L: Postischemic infusion of adrenomedullin protects against
ischemic stroke by inhibiting apoptosis and promoting angiogenesis.
Exp Neurol. 197:521–530. 2006. View Article : Google Scholar
|
|
54
|
Wang X, Yue TL, Barone FC, White RF, Clark
RK, Willette RN, Sulpizio AC, Aiyar NV, Ruffolo RR Jr and
Feuerstein GZ: Discovery of adrenomedullin in rat ischemic cortex
and evidence for its role in exacerbating focal brain ischemic
damage. Proc Natl Acad Sci USA. 92:11480–11484. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Pedreño M, Morell M, Robledo G,
Souza-Moreira L, Forte-Lago I, Caro M, O'Valle F, Ganea D and
Gonzalez-Rey E: Adrenomedullin protects from experimental
autoimmune encephalomyelitis at multiple levels. Brain Behav Immun.
37:152–163. 2014. View Article : Google Scholar :
|
|
56
|
Ma S, Zhao H, Ji X and Luo Y: Peripheral
to central: Organ interactions in stroke pathophysiology. Exp
Neurol. 272:41–49. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Liu J, Yan J, Greer JM, Read SJ, Henderson
RD, Rose SE, Coulthard A and McCombe PA: Correlation of
adrenomedullin gene expression in peripheral blood leukocytes with
severity of ischemic stroke. Int J Neurosci. 124:271–280. 2014.
View Article : Google Scholar
|
|
58
|
Malfitano AM, Marasco G, Proto MC, Laezza
C, Gazzerro P and Bifulco M: Statins in neurological disorders: An
overview and update. Pharmacol Res. 88:74–83. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Yamamoto C, Fukuda N, Jumabay M, Saito K,
Matsumoto T, Ueno T, Soma M, Matsumoto K and Shimosawa T:
Protective effects of statin on cardiac fibrosis and apoptosis in
adrenomedullin-knockout mice treated with angiotensin II and high
salt loading. Hypertens Res. 34:348–353. 2011. View Article : Google Scholar
|
